News Epillo to pilot blockchain-based DTx with Hydrus7 European digital health firm Epillo is to launch a pilot digital therapeutics (DTx) project in a strategic partnership with US-based blockchain firm Hydrus7 Labs.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.